Biomarkers, Advanced Therapies, and New Targets Drive Change in Parkinson’s Research

by Hospital de la Santa Creu i Sant Pau

Parkinson’s disease is the second most common neurodegenerative disorder and affects more than 160,000 people in Spain, with an estimated prevalence of between 20,000 and 25,000 patients in Cataloni...

Read more

Proyecto MELIPOP: el estilo de vida mediterráneo podría frenar la obesidad infantil desde la etapa preescolar

by CIBERobn- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición

Un ensayo clínico ha mostrado que una intervención basada en alimentación mediterránea y actividad física puede mejorar la composición corporal en menores de entre 3 y 6 años con riesgo de obes...

Read more

Navigating EU-UK Dual-Track Clinical Trial Regulation in Parallel

by Pivotal

How sponsors can leverage both the EU Clinical Trials Regulation and UK’s reformed framework to achieve cost efficiencies, faster timelines, and stronger regulatory positioning.

Read more

Iteria Biopharma closes a €5M seed round led by Inveready

by Inveready

With this capital injection, the biotechnology company covers its financial requirements to complete the preclinical development and the first clinical trial of ITR-251, a novel drug for the treatment...

Read more

The CATHERINE trial begins as the first clinical trial of an innovative CAR-T therapy that triggers a dual anti-tumour response in HER2+ solid tumours

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del Mar Research Institute, has been administered to patients for the first t...

Read more

Una estrategia de vacunación personalizada podría ayudar a más pacientes con cáncer de hígado a responder a la inmunoterapia

by CIMA - Centro de Investigación Médica Aplicada

Investigadores del Cancer Center Clínica Universidad de Navarra (CCUN), en colaboración con un grupo del Hospital Clínic de Barcelona, han desarrollado una estrategia de vacunación que permite pot...

Read more

New evidence highlights antibody durability as a key factor to improve the RTS,S malaria vaccine

by ISGlobal - Instituto de Salud Global de Barcelona

Antibodies against the C-terminal region of the CSP protein of 'P. falciparum' may better predict protection than traditional peak responses

Read more

Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit ™, as it moves to commercialization

by Ysios Capital

CE mark awarded for aXess™ at record speed, underpinned by strong EU pivotal trial data

Read more

Consuming ultra-processed foods during pregnancy is associated with more than double the risk of developing preeclampsia

by Institut de Recerca Sant Joan de Déu - IRSJD

According to the researchers, these results suggest that promoting healthy eating patterns during pregnancy, such as the Mediterranean diet, could be an effective strategy for improving maternal diet ...

Read more

Investigadores españoles describen por primera vez la actividad antitumoral de inhibidores RAS en modelos preclínicos de colangiocarcinoma

by Cima Universidad de Navarra

Investigadores del Cima Universidad de Navarra, en colaboración con Revolution Medicines, han publicado un estudio que evalúa por primera vez la actividad antitumoral de los inhibidores RAS en el co...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream